Biggest News Aggregation in the World
📰 C10 News

Page 113 - C10 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from C10. Real-time updates on events, politics, business and more.

Vaxart (NASDAQ:VXRT) vs. Alvotech (NYSE:ALVO) Head to Head Contrast

Vaxart (NASDAQ:VXRT – Get Free Report) and Alvotech (NYSE:ALVO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, dividends, profitability and institutional ownership. Risk and Volatility Vaxart has a beta of 0.43, meaning […]
South San Francisco United States Altesa Biosciences Inc Vaxart Inc Get Free Report Given Vaxart

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Analyzing Titan Pharmaceuticals (NASDAQ:TTNP) and Alvotech (NYSE:ALVO)

Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) and Alvotech (NYSE:ALVO – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk and institutional ownership. Insider and Institutional Ownership 31.5% of Titan Pharmaceuticals shares […]
South San Francisco United States European Union Titan Pharmaceuticals Titan Pharmaceuticals Inc News Ratings For Titan Pharmaceuticals Daily

Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira® -February 23, 2024 at 08:16 pm EST

SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership...
New Zealand United States Republic Of South Africa South Korea Yangtze River

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science